NCT00001005View on ClinicalTrials.gov

A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1995

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Aldesleukin

Trial Locations (1)

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH